Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 33B pseudogene 1 (ZNF33BP1) is a pseudogene in humans, not a protein-coding gene or functional molecule. It is related in name and sequence to zinc finger protein 33B—but does not produce a functional protein. ZNF33BP1 is classified as a pseudogene locus type, with no established biological function, mechanism of action, disease association, or therapeutic relevance. As a pseudogene, ZNF33BP1 is not a target for pharmacological intervention or clinical assays[3][4][6][7][10]. Key notes: - ZNF33BP1 is specifically annotated as a pseudogene by genomic resources, not an active gene with protein-coding capacity, hence not a valid therapeutic target[6][7]. - Zinc finger protein 33B (ZNF33B) is a protein-coding gene and transcription factor, but ZNF33BP1 is not its functional form and does not encode a receptor, enzyme, or targetable protein[1][3]. - There are no recorded aliases or molecular functions for ZNF33BP1, and it lacks any established role in disease or therapeutic applications. This entry is not a druggable target due to its pseudogene status and absence of supporting evidence for any function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 33B pseudogene 1 (ZNF33BP1).